IDEX Corporation reported adjusted earnings of $2.07 per share for Q2 2025, exceeding the Zacks Consensus Estimate of $2.00. The company’s net sales reached $865.4 million, surpassing expectations of $857 million and marking a 7% year-over-year increase.
IEX’s Revenue Breakdown
Sales from the Fluid & Metering Technologies segment were $310.9 million, down 3% year-over-year. The Health & Science Technologies segment saw a 20% increase to $365.3 million, while the Fire & Safety/Diversified Products segment rose 3% to $191.5 million.
Financial Metrics
The adjusted gross margin was 45.3%, slightly down from 45.4% a year ago. Net cash from operating activities for the first half of 2025 totaled $267.4 million, a decrease of 7.9% year-over-year. IDEX expects Q3 adjusted earnings in the range of $1.90-$1.95 per share and a 2025 projection of adjusted earnings between $7.85-$7.95 per share.
